Adaptation of oral medication in people institutionalized in nursing homes for whom medication is crushed: the ADECUA study

FC Apolo Carvajal, M González Martínez… - Farm …, 2016 - pesquisa.bvsalud.org
Purpose: To evaluate the effect of pharmacist interventions in the adaptation of
pharmaceutical forms in elders institutionalized in nursing homes whose medicines are …

2SPD-014 Appropriateness of ustekinumab therapy prescription and real-life condition use in Crohn's disease

NM Casanova, ES Yañez, MG Delgado - 2022 - ejhp.bmj.com
Background and importance For the patient with moderate to severe Crohn's disease, first-
line options for induction therapy include a biologic agent. Tumour necrosis factor alpha …

5PSQ-150 Disseminated intravascular coagulation after PD-1 blockade with nivolumab in advanced melanoma: a case report

…, M Sánchez-Argaiz, N Martinez-Casanova… - 2021 - ejhp.bmj.com
Background and importance Immune checkpoint inhibitors (ICIs) represent a milestone
therapy in many types of cancer, such as melanoma. Nivolumab is a programmed death …

4CPS-338 Use and efficacy of tocilizumab in patients with severe COVID-19 pneumonia

JLO Latorre, NM Casanova, CP Lopez, ES Yañez… - 2021 - ejhp.bmj.com
Background and importance Tocilizumab is an anti-human IL-6 receptor monoclonal
antibody used in the treatment of cytokine release syndrome in patients with pneumonia …

Remdesivir use and efficacy in patients with severe SARS-CoV-2 pneumonia

M Gómez Delgado, JL Ortiz Latorre… - … Journal of Hospital …, 2022 - pesquisa.bvsalud.org
Background and importanceRemdesivir is a viral RNA polymerase inhibitor. After the NIAID
ACTT-1 study results, it currently is an antiviral medicine used to treat coronavirus disease …

DI-053 Multicenter study to determine the safety of protease inhibitors in patients infected with hepatitis C virus

R López-Sepúlveda, C Fernández-López… - European Journal of …, 2014 - ejhp.bmj.com
Background Boceprevir (BOC) and telaprevir (TLV) have been approved recently for the
treatment of chronic hepatitis C virus (HCV) infection but their safety remains to be studied …

CP-007 Switching from intravenous to subcutaneous formulation of abatacept in a real world setting

R López-Sepúlveda, NM Casanova, IV Rodríguez… - 2016 - ejhp.bmj.com
Background The switch from the intravenous (IV) formulation to the subcutaneous (SC)
formulation of abatacept (ABA) had been analysed in clinical trials but there are few data …

Measurement of methotrexate in cerebrospinal fluid by fluorescence polarisation immunoassay in patient with medulloblastoma

…, I Vallejo-Rodriguez, N Martinez-Casanova… - European Journal of …, 2012 - ejhp.bmj.com
Background Medulloblastoma is one of the most frequent malignant brain tumours in
infancy. Conventional treatment is based on combined radiotherapy and chemotherapy after …

4CPS-164 A safe handling hazardous drugs strategy to improve the safety of health professionals: reducing exposure by medical prescription review in nursing homes

IC Orbis, FA Carvajal, MG Martinez, EC Santamaria… - 2020 - ejhp.bmj.com
Background and importance The occupational risk due to exposure to hazardous drugs
(HDs) has been a mounting concern to healthcare professionals, including in nursing …

DI-076 Pirfenidone: compassionate use in two patients with idiopathic pulmonary fibrosis

…, C Valencia-Soto, N Martinez-Casanova… - European Journal of …, 2014 - ejhp.bmj.com
Background Pirfenidone is currently the only agent approved for mild to moderate idiopathic
pulmonary fibrosis (IPF) in adults. Purpose To evaluate the effect of pirfenidone in two …